CUSIP 89532M101 · who reports it, how much, and how much it matters to them
23 of the 720 hedge fund managers we track reported shares of Trevi Therapeutics, Inc. (Nasdaq: TRVI) on Form 13F for 30 June 2026. Between them they reported USD 262m. The largest position belongs to Marshall Wace LLP, at USD 50m. The manager with the most riding on it is Artia Global Partners, where it is 7.6% of the reported book.
Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated
Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.
A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.
Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.
The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Marshall Wace LLP84 funds on PPLI.com | USD 50m | 0.0% |
| 2 | Artia Global Partners1 fund on PPLI.com | USD 41m | 7.6% |
| 3 | Logos Global Management1 fund on PPLI.com | USD 35m | 1.5% |
| 4 | Viking Global Investors4 funds on PPLI.com | USD 29m | 0.1% |
| 5 | Orbimed Advisors1 fund on PPLI.com | USD 27m | 0.5% |
| 6 | Balyasny Asset Management25 funds on PPLI.com | USD 16m | 0.0% |
| 7 | Burkehill Global Management5 funds on PPLI.com | USD 14m | 0.5% |
| 8 | Superstring Capital Management1 fund on PPLI.com | USD 9.8m | 6.2% |
| 9 | Sphera Funds Management1 fund on PPLI.com | USD 9.3m | 1.2% |
| 10 | Octagon Capital Advisors1 fund on PPLI.com | USD 5.9m | 0.5% |
| 11 | D. E. Shaw & Co.15 funds on PPLI.com | USD 5.3m | 0.0% |
| 12 | Rock Springs Capital Management2 funds on PPLI.com | USD 4.8m | 0.2% |
| 13 | Walleye Capital8 funds on PPLI.com | USD 4.5m | 0.0% |
| 14 | LMR Partners2 funds on PPLI.com | USD 1.9m | 0.0% |
| 15 | Wexford Capital8 funds on PPLI.com | USD 1.7m | 0.2% |
| 16 | Campbell & Company Investment Adviser8 funds on PPLI.com | USD 1.5m | 0.1% |
| 17 | J. Goldman & Co.1 fund on PPLI.com | USD 1.5m | 0.0% |
| 18 | Schonfeld Strategic Advisors30 funds on PPLI.com | USD 1.4m | 0.0% |
| 19 | Tudor Investment Corporation10 funds on PPLI.com | USD 1.4m | 0.0% |
| 20 | HighVista Strategies27 funds on PPLI.com | USD 989,000 | 0.2% |
| 21 | Persistent Asset Partners10 funds on PPLI.com | USD 477,000 | 0.1% |
| 22 | Brevan Howard Capital Management39 funds on PPLI.com | USD 460,000 | 0.0% |
| 23 | Graham Capital Management18 funds on PPLI.com | USD 335,000 | 0.0% |
A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Artia Global Partners | USD 41m | 7.6% |
| 2 | Superstring Capital Management | USD 9.8m | 6.2% |
| 3 | Logos Global Management | USD 35m | 1.5% |
| 4 | Sphera Funds Management | USD 9.3m | 1.2% |
| 5 | Octagon Capital Advisors | USD 5.9m | 0.5% |
| 6 | Orbimed Advisors | USD 27m | 0.5% |
| 7 | Burkehill Global Management | USD 14m | 0.5% |
| 8 | Rock Springs Capital Management | USD 4.8m | 0.2% |
| 9 | HighVista Strategies | USD 989,000 | 0.2% |
| 10 | Wexford Capital | USD 1.7m | 0.2% |
Trevi Therapeutics, Inc. trades under the symbol TRVI on the Nasdaq. Its CUSIP, the code used on Form 13F, is 89532M101.
23 of the 720 hedge fund managers PPLI.com tracks reported Trevi Therapeutics, Inc. shares on Form 13F for 30 June 2026. The largest reported positions were held by Marshall Wace LLP (USD 50m), Artia Global Partners (USD 41m), Logos Global Management (USD 35m), Viking Global Investors (USD 29m) and Orbimed Advisors (USD 27m).
23 managers in our coverage reported it, and between them they run 302 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.
Artia Global Partners, where the position was 7.6% of the reported 13F book at 30 June 2026.
No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.
Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Trevi Therapeutics, Inc. or with the managers listed.
Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.
Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.